Neuland Laboratories
₹7,484.9
-46.75
(-0.62%)
30 June, 2024 22:53
BSE:
524558
NSE:
NEULANDLAB
ISIN:
INE794A01010
Start SIP in Neuland Laboratories
Start SIPNeuland Laboratories Performance
Day Range
- Low 7,211
- High 7,635
52 Week Range
- Low 2,786
- High 7,790
- Open Price7,570
- Previous Close7,532
- Volume37367
Neuland Laboratories Financials
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 385 | 393 | 418 | 363 | 407 |
Operating Expenses Qtr Cr | 278 | 272 | 280 | 266 | 287 |
Operating Profit Qtr Cr | 107 | 121 | 137 | 97 | 120 |
Depreciation Qtr Cr | 16 | 15 | 15 | 14 | 13 |
Interest Qtr Cr | 4 | 4 | 4 | 2 | 4 |
Tax Qtr Cr | 24 | 23 | 32 | 21 | 26 |
Net Profit Qtr Cr | 68 | 81 | 89 | 62 | 85 |
Neuland Laboratories Technicals
EMA & SMA
Current Price
₹7,484.9
-46.75
(-0.62%)
![pointer pointer](https://cdn-static.trendlyne.com/static/img/brokerwebview/pointer.png)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹6,770.72
- 50 Day
- ₹6,630.54
- 100 Day
- ₹6,410.77
- 200 Day
- ₹5,713.88
- 20 Day
- ₹6,578.30
- 50 Day
- ₹6,732.79
- 100 Day
- ₹6,653.14
- 200 Day
- ₹5,710.21
Neuland Laboratories Resistance and Support
PIVOT
₹7,443.57
Resistance | |
---|---|
First Resistance | 7,676.33 |
Second Resistance | 7,867.77 |
Third Resistance | 8,100.53 |
RSI | 70.97 |
MFI | 79.66 |
MACD Single Line | 86.92 |
MACD | 228.21 |
Support | |
---|---|
First Support | 7,252.13 |
Second Support | 7,019.37 |
Third Supoort | 6,827.93 |
Neuland Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 97,910 | 8,104,990 | 82.78 |
Week | 103,494 | 7,036,571 | 67.99 |
1 Month | 47,585 | 3,031,155 | 63.7 |
6 Month | 46,685 | 2,846,400 | 60.97 |
Neuland Laboratories Result Highlights
Neuland Laboratories Synopsis
NSE-Medical-Diversified
Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1558.58 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2024. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.Market Cap | 9,603 |
Sales | 1,559 |
Shares in Float | 0.86 |
No of funds | 175 |
Yield | 0.22 |
Book Value | 7.56 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | 4 |
Alpha | 0.25 |
Beta | 0.97 |
Neuland Laboratories Shareholding Pattern
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 32.74% | 32.8% | 35.97% | 36.03% |
Mutual Funds | 3.88% | 1.83% | 1.94% | 1.57% |
Foreign Portfolio Investors | 24.43% | 22.69% | 21.57% | 20.19% |
Individual Investors | 27.97% | 29.52% | 27.86% | 29.01% |
Others | 10.98% | 13.16% | 12.66% | 13.2% |
Neuland Laboratories Management
Name | Designation |
---|---|
Dr. Davuluri Rama Mohan Rao | Executive Chairman |
Mr. Davuluri Sucheth Rao | Vice Chairman & CEO |
Mr. Davuluri Saharsh Rao | Vice Chairman & Mng.Director |
Dr. Christopher M Cimarusti | Non Executive Director |
Mr. Humayun Dhanrajgir | Ind. Non-Executive Director |
Mrs. Bharati Rao | Ind. Non-Executive Director |
Dr. Nirmala Murthy | Ind. Non-Executive Director |
Mr. Parampally Vasudeva Maiya | Ind. Non-Executive Director |
Mr. Homi Rustum Khusrokhan | Ind. Non-Executive Director |
Mr. Prasad Raghava Menon | Ind. Non-Executive Director |
Neuland Laboratories Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Neuland Laboratories Corporate Action
Neuland Laboratories FAQs
What is Share Price of Neuland Laboratories ?
Neuland Laboratories share price is ₹7,484 As on 30 June, 2024 | 22:39
What is the Market Cap of Neuland Laboratories ?
The Market Cap of Neuland Laboratories is ₹9603.1 Cr As on 30 June, 2024 | 22:39
What is the P/E ratio of Neuland Laboratories ?
The P/E ratio of Neuland Laboratories is 32 As on 30 June, 2024 | 22:39
What is the PB ratio of Neuland Laboratories ?
The PB ratio of Neuland Laboratories is 7.5 As on 30 June, 2024 | 22:39